Over 2mill traded and we're back to square 1, 13c. Obviously not the announcement investors are looking for. On this basis doubt that announcement of commencement of multi-dose trials will have any material effect on the share price. ENA growth certainly having no short-term effect. Any other driver that might push the share price up in the shorter-term?
oxymorphone patch m eets phase 1 end points, page-19
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.366K | 455.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 99145902 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 22467224 | 7 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |